Icu Medical (ICUI) Research & Development (2009 - 2026)

Icu Medical has reported Research & Development for 18 years, with the latest figure at $21.3 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 8.63% year-over-year to $21.3 million; the trailing twelve-month figure through Mar 2026 stood at $85.5 million (down 5.09% YoY), and the FY2025 full-year result was $87.5 million, down 1.26% from the prior year.
• Research & Development for Q1 2026 stood at $21.3 million, up from $21.1 million in the prior quarter.
• The five-year high for Research & Development was $23.9 million in Q1 2022, with the low at $19.8 million in Q1 2023.
• Historically, Research & Development has averaged $22.1 million across 5 years, with a median of $22.3 million in 2023.
• Annual changes were most pronounced in 2022 — Research & Development jumped 122.91% — and 2023, when it retreated 17.22%.
• Icu Medical's Research & Development stood at $23.4 million in 2022, then retreated by 4.41% to $22.4 million in 2023, then dropped by 0.25% to $22.4 million in 2024, then retreated by 5.68% to $21.1 million in 2025, then grew by 0.92% to $21.3 million in 2026.
• The last three Research & Development figures came in at $21.3 million (Q1 2026), $21.1 million (Q4 2025), and $21.3 million (Q3 2025), per Business Quant data.